BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model.
Saved in:
| Title: | BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model. |
|---|---|
| Authors: | Bicak, Mesude, Perez‐Garcia, Georgina E., Buros, Jacqueline, Haure‐Mirande, Jean‐Vianney, Perez, Gissel E., Otero‐Pagan, Alena, Gama‐Sosa, Miguel E., DeGasperi, Rita E., Sano, Mary, Gage, Fred H., Barlow, Carrolee, Dudley, Joel, Glicksberg, Benjamin S., Wang, Yanzhuang, Readhead, Benjamin, Ehrlich, Michelle E., Elder, Gregory A., Gandy, Sam |
| Source: | Alzheimer's & dementia: the journal of the Alzheimer's Association Dec2022 Supplement 10; Vol. 18 (10). |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 1552-5260 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.062751 |
